Yoshii Ichiro, Chijiwa Tatsumi, Sawada Naoya
Department of Rheumatology and Musculoskeletal Medicine, Yoshii Hospital, 6-7-5 Nakamura-Ohashidori, Shimanto City, 787-0033 Kochi prefecture, Japan.
Department of Rheumatology, Kochi Memorial Hospital, 4-13 Shiromi-cho, Kochi, 780-0824 Kochi Prefecture, Japan.
J Orthop Sci. 2020 Jul;25(4):671-676. doi: 10.1016/j.jos.2019.07.002. Epub 2019 Jul 20.
Screening osteoporosis in Japanese postmenopausal women is an important subject for preventing bone fragility fracture (BFF). Measuring bone mineral density (BMD) is included in the criteria for osteoporosis diagnosis. However, it has not gained popularity.
BMD of lumbar spine (LS) and femoral neck (FN) were measured, the serum creatinine-to-cystatin C ratio (Cr/CysC), tartrate-resistant acid phosphatase-5b (TRACP-5b), body mass index (BMI) were also simultaneously measured. These subjects had no potential secondary osteoporosis factors or concomitant drug administration for osteoporosis (pSubjects; primary subjects). Best subsets regression analysis (BeStR) was evaluated for determining the statistically significant factors, and multivariate regression analysis (MLR) was used to assess the correlation of these factors with BMD at each part. Relationship between osteoporotic criteria whether T score≤-2.5 and each factor was also evaluated at each part with binary logistic regression analysis (BLR). Cut-off index (COI) at each part was determined, and sensitivity and specificity were evaluated in pSubjects and in subjects with whom potential secondary osteoporosis factors were included (sSubjects).
BMI and Cr/CysC had a significant influence on BMD at the LS with BeStR, whereas only BMI demonstrated significant correlation with BMD both with MLR and BLR, with 22.7 of COI and sensitivity and specificity of 48.7% and 94.7%, respectively, in pSubjects with 60 and 49.1% and 87.5%, respectively, in sSubjects with 83. At the FN, Cr/CysC, BMI, and TRACP-5b significantly influenced BMD, whereas all these factors demonstrated significant correlation with BMD. Cr/CysC and TRACP-5b demonstrated significant correlation with T score≤-2.5 in BLR. With COI that was made in combination with these factors and subjects' age, sensitivity and specificity were 67.7% and 82.4%, respectively, in pSubjects and 55.8% and 82.8%, respectively, in sSubjects.
These results suggested that BMI, TRACP-5b, and Cr/CysC may be realistic surrogate markers for screening osteoporosis in Japanese postmenopausal women.
对日本绝经后女性进行骨质疏松症筛查是预防脆性骨折(BFF)的重要课题。测量骨密度(BMD)被纳入骨质疏松症诊断标准。然而,该方法尚未普及。
测量腰椎(LS)和股骨颈(FN)的骨密度,同时测量血清肌酐与胱抑素C比值(Cr/CysC)、抗酒石酸酸性磷酸酶-5b(TRACP-5b)、体重指数(BMI)。这些受试者无潜在的继发性骨质疏松因素或用于骨质疏松症的伴随药物治疗(p受试者;主要受试者)。采用最佳子集回归分析(BeStR)确定统计学显著因素,多元回归分析(MLR)评估这些因素与各部位骨密度的相关性。采用二元逻辑回归分析(BLR)在各部位评估骨质疏松症标准(T评分≤-2.5)与各因素之间的关系。确定各部位的截断指数(COI),并在p受试者和包含潜在继发性骨质疏松因素的受试者(s受试者)中评估敏感性和特异性。
BeStR分析显示,BMI和Cr/CysC对LS的骨密度有显著影响,而在MLR和BLR中,只有BMI与骨密度显示出显著相关性,在p受试者中COI为22.7,敏感性和特异性分别为48.7%和94.7%,在83例s受试者中分别为60和49.1%以及87.5%。在FN,Cr/CysC、BMI和TRACP-5b对骨密度有显著影响,而所有这些因素与骨密度均显示出显著相关性。在BLR中,Cr/CysC和TRACP-5b与T评分≤-2.5显示出显著相关性。结合这些因素和受试者年龄得出的COI,在p受试者中敏感性和特异性分别为67.7%和82.4%,在s受试者中分别为55.8%和82.8%。
这些结果表明,BMI、TRACP-5b和Cr/CysC可能是日本绝经后女性骨质疏松症筛查的现实替代指标。